本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Palvella Therapeutics

150.56
-3.7600-2.44%
盤後150.700.1400+0.09%19:30 EDT
成交量:64.65萬
成交額:9,753.20萬
市值:21.69億
市盈率:-30.74
高:154.72
開:154.72
低:149.20
收:154.32
52周最高:161.38
52周最低:56.22
股本:1,440.84萬
流通股本:839.81萬
量比:3.36
換手率:7.70%
股息:- -
股息率:- -
每股收益(TTM):-4.8978
每股收益(LYR):-3.7076
淨資產收益率:-46.63%
總資產收益率:-22.05%
市淨率:10.00
市盈率(LYR):-40.61

資料載入中...

2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/08/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report